Detalhe da pesquisa
1.
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(2): 231-244, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938772
2.
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
Br J Haematol
; 180(6): 821-830, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435979
3.
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
Blood
; 123(10): 1487-98, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24435047
4.
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Blood
; 120(9): 1801-9, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665938
5.
More than an Incidentaloma: The Nonreportable NIPT.
Case Rep Obstet Gynecol
; 2022: 2496057, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535117
6.
Choroidal effusion: a rare and unusual complication of daratumumab.
BMJ Case Rep
; 15(8)2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914801
7.
TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment.
Mediterr J Hematol Infect Dis
; 14(1): e2022018, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444774
8.
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
JAMA Netw Open
; 5(12): e2242918, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469321
9.
Lung cancer after 70: is it a different disease?
Oncology (Williston Park)
; 24(12): 1106-11, 1114, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21141691
10.
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.
Haematologica
; 99(9): e162-4, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972772
11.
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Clin Cancer Res
; 23(5): 1167-1176, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601593
12.
Sweet syndrome: a painful reality.
BMJ Case Rep
; 20162016 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011887
13.
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.
Clin Cancer Res
; 22(1): 34-43, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26561559
14.
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
J Clin Oncol
; 34(23): 2698-704, 2016 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269947
15.
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab.
Leuk Lymphoma
; 56(2): 342-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24730538
16.
Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial.
Leuk Lymphoma
; 52(7): 1271-80, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699382
17.
Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.
Clin Lymphoma Myeloma Leuk
; 11(6): 507-11, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813352
18.
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis.
Leuk Lymphoma
; 51(6): 1015-9, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20367570